Clinical Trial Update: Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin hydrochloride to prevent progression to oral cancer in patients with premalignant oral lesions (erythroplakia and oral leukop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythroplakia
• Oral Leukoplakia
• Oral Squamous Cell Carcinoma

Drugs mentioned

• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Erythroplakia, Hyperplasia | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2019-05-23